e-learning
resources
Paris 2018
Saturday, 15.09.2018
PG11 Modern approaches in lung cancer diagnostics and therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Modern molecular lung cancer diagnostics – how to use and interpret it wisely
J. Chorostowska-Wynimko (Warsaw, Poland)
Source:
International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Session:
PG11 Modern approaches in lung cancer diagnostics and therapy
Session type:
Postgraduate Course
Number:
114
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Chorostowska-Wynimko (Warsaw, Poland). Modern molecular lung cancer diagnostics – how to use and interpret it wisely. International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
PG11 Modern approaches in lung cancer diagnostics and therapy
Source: Paris 2018 - Educational material
Year: 2018
High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009
Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
Source: Eur Respir J 2014; 44: 1011-1022
Year: 2014
Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
Complexity of diagnostics of complicated lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004
New findings in the molecular biology of lung cancer: clinical application
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
The electronic nose: emerging biomarkers in lung cancer diagnostics
Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019
Year: 2019
Evolution in the diagnostic approach to lung cancer
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Precision medicine for lung cancer: new targeted treatments
Source: International Congress 2017 – Precision medicine approaches in lung cancer
Year: 2017
Radiomics in lung cancer: progress and challenges
Source: Virtual Congress 2021 – Chinese programme 2021
Year: 2021
What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities
Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules
Year: 2018
Modern profiling of advanced lung cancer at the primary diagnosis and during therapy
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018
Cytological diagnostics of lung cancer: our experience
Source: Eur Respir J 2005; 26: Suppl. 49, 306s
Year: 2005
Exploiting metabolomic approaches to aid in the diagnosis of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
PG1 Re-defining the role of chest physicians in lung cancer:ÿnew opportunities in diagnostics and therapy
Source: Milan 2017 - Educational material
Year: 2017
Pathology and molecular biology of lung cancer
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006
Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept